Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wayne Kepner

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Journal of Affective Disorders|January 2, 2025
Trends and characteristics in ketamine use among US adults with and without depression, 2015-2022Kevin H Yang, Wayne Kepner, Charles M Cleland, et al.
Journal of Cannabis Research|December 10, 2025
Prevalence and reasons for using cannabidiol, delta-8 tetrahydrocannabinol, cannabinol, cannabigerol, and hexahydrocannabinol among US adultsNora Satybaldiyeva, Kevin H Yang, Wayne Kepner, et al.
Addictive Behaviors Reports|December 17, 2024
Emergency care utilization in persons with substance related diagnosesWayne Kepner, Natasia S Courchesne-Krak, Nora Satybaldiyeva, et al.
Journal of Addiction Medicine|October 3, 2023
Prevalence and Correlates of Past Year Ecstasy/MDMA Use in the United StatesKevin H Yang, Wayne Kepner, Anamika Nijum, et al.
American Journal of Preventive Medicine|May 7, 2026
Prevalence and Reasons for Microdosing Cannabis, Psilocybin, LSD, and MDMA Among US AdultsKevin H Yang, Nora Satybaldiyeva, Wayne Kepner, et al.
Aging & Mental Health|January 23, 2026
Associations between loneliness severity and depression and suicidal ideation among older adults during the COVID-19 pandemicKevin H Yang, Wayne Kepner, Nora Satybaldiyeva, et al.
Journal of General Internal Medicine|January 14, 2026
Implementation Outcomes of Low Threshold Care for Persons with Opioid Use DisordersWayne Kepner, Hannah Cheng, Berkeley Franz, et al.
Journal of Psychoactive Drugs|May 19, 2026
Association Between Lifetime Hallucinogen Use and Valvular Heart Disease: Findings from the All of Us Research ProgramKevin H Yang, Miranda Rasmussen, Kush Bhatt, et al.
Harm Reduction Journal|July 9, 2026
Integrating harm reduction interventions for older adults in opioid treatment programs: a qualitative study of patient and provider perspectivesWayne Kepner, Benjamin H Han, Annie L Nguyen, et al.
Journal of Psychoactive Drugs|March 3, 2025
Prevalence and Correlates of Lifetime Ecstasy/MDMA Use Among Asian American and Pacific Islander Adult Populations in the United States, 2015-2020Wayne Kepner, Kevin H Yang, Patricia Dionicio, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Journal of Affective Disorders|January 2, 2025
Trends and characteristics in ketamine use among US adults with and without depression, 2015-2022Kevin H Yang, Wayne Kepner, Charles M Cleland, et al.
Journal of Cannabis Research|December 10, 2025
Prevalence and reasons for using cannabidiol, delta-8 tetrahydrocannabinol, cannabinol, cannabigerol, and hexahydrocannabinol among US adultsNora Satybaldiyeva, Kevin H Yang, Wayne Kepner, et al.
Addictive Behaviors Reports|December 17, 2024
Emergency care utilization in persons with substance related diagnosesWayne Kepner, Natasia S Courchesne-Krak, Nora Satybaldiyeva, et al.
Journal of Addiction Medicine|October 3, 2023
Prevalence and Correlates of Past Year Ecstasy/MDMA Use in the United StatesKevin H Yang, Wayne Kepner, Anamika Nijum, et al.
American Journal of Preventive Medicine|May 7, 2026
Prevalence and Reasons for Microdosing Cannabis, Psilocybin, LSD, and MDMA Among US AdultsKevin H Yang, Nora Satybaldiyeva, Wayne Kepner, et al.
Aging & Mental Health|January 23, 2026
Associations between loneliness severity and depression and suicidal ideation among older adults during the COVID-19 pandemicKevin H Yang, Wayne Kepner, Nora Satybaldiyeva, et al.
Journal of General Internal Medicine|January 14, 2026
Implementation Outcomes of Low Threshold Care for Persons with Opioid Use DisordersWayne Kepner, Hannah Cheng, Berkeley Franz, et al.
Journal of Psychoactive Drugs|May 19, 2026
Association Between Lifetime Hallucinogen Use and Valvular Heart Disease: Findings from the All of Us Research ProgramKevin H Yang, Miranda Rasmussen, Kush Bhatt, et al.
Harm Reduction Journal|July 9, 2026
Integrating harm reduction interventions for older adults in opioid treatment programs: a qualitative study of patient and provider perspectivesWayne Kepner, Benjamin H Han, Annie L Nguyen, et al.
Journal of Psychoactive Drugs|March 3, 2025
Prevalence and Correlates of Lifetime Ecstasy/MDMA Use Among Asian American and Pacific Islander Adult Populations in the United States, 2015-2020Wayne Kepner, Kevin H Yang, Patricia Dionicio, et al.
Pageof 3